Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric R Bates

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
ACP Journal Club|July 3, 2002
Review: glycoprotein IIb/IIIa inhibitors reduced death or MI in acute coronary syndromes not routinely scheduled for revascularizationEric R Bates
Circulation|July 20, 2011
Treatment options in severe aortic stenosisEric R Bates
Annals of Internal Medicine|June 18, 2019
After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placeboEric R Bates
Circulation|July 8, 2015
Response to Letter Regarding Article, "Evolution From Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients With ST-Segment-Elevation Myocardial Infarction"Eric R Bates
Annals of Internal Medicine|March 21, 2017
Review: In AF, direct oral anticoagulants reduce all-cause and vascular mortality compared with warfarinEric R Bates
The New England Journal of Medicine|January 24, 2017
Drug-Eluting or Bare-Metal Stents for Coronary Artery DiseaseEric R Bates
Expert Review of Cardiovascular Therapy|May 21, 2004
Bivalirudin: an anticoagulant option for percutaneous coronary interventionEric R Bates
JAMA Cardiology|October 12, 2022
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?Eric R Bates
The New England Journal of Medicine|September 3, 2019
Antiplatelet Therapy in Patients with Coronary Disease and Type 2 DiabetesEric R Bates
ACP Journal Club|November 4, 2006
Early revascularization improved long-term survival after myocardial infarction with cardiogenic shockEric R Bates
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
ACP Journal Club|July 3, 2002
Review: glycoprotein IIb/IIIa inhibitors reduced death or MI in acute coronary syndromes not routinely scheduled for revascularizationEric R Bates
Circulation|July 20, 2011
Treatment options in severe aortic stenosisEric R Bates
Annals of Internal Medicine|June 18, 2019
After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placeboEric R Bates
Circulation|July 8, 2015
Response to Letter Regarding Article, "Evolution From Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients With ST-Segment-Elevation Myocardial Infarction"Eric R Bates
Annals of Internal Medicine|March 21, 2017
Review: In AF, direct oral anticoagulants reduce all-cause and vascular mortality compared with warfarinEric R Bates
The New England Journal of Medicine|January 24, 2017
Drug-Eluting or Bare-Metal Stents for Coronary Artery DiseaseEric R Bates
Expert Review of Cardiovascular Therapy|May 21, 2004
Bivalirudin: an anticoagulant option for percutaneous coronary interventionEric R Bates
JAMA Cardiology|October 12, 2022
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?Eric R Bates
The New England Journal of Medicine|September 3, 2019
Antiplatelet Therapy in Patients with Coronary Disease and Type 2 DiabetesEric R Bates
ACP Journal Club|November 4, 2006
Early revascularization improved long-term survival after myocardial infarction with cardiogenic shockEric R Bates
Pageof 24